Black Diamond Therapeutics (BDTX)
(Real Time Quote from BATS)
$4.77 USD
+0.03 (0.63%)
Updated May 24, 2024 02:24 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Black Diamond Therapeutics, Inc. [BDTX]
Reports for Purchase
Showing records 81 - 85 ( 85 total )
Company: Black Diamond Therapeutics, Inc.
Industry: Medical - Drugs
Company: Black Diamond Therapeutics, Inc.
Industry: Medical - Drugs
BDTX-189 Receives Fast Track Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Black Diamond Therapeutics, Inc.
Industry: Medical - Drugs
ASCO Updates - We''re Keeping a Close Eye on Amivantamab and Enhertu; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Black Diamond Therapeutics, Inc.
Industry: Medical - Drugs
Competitive Landscape Updates at ASCO 2020; 1Q20 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Black Diamond Therapeutics, Inc.
Industry: Medical - Drugs
Breaking the Mold in Precision Oncology; Initiating at Buy and $53 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R